Jimmy Gomez addresses affordability and healthcare issues in recent tweets

Jimmy Gomez U.S. House of Representatives from California's 34th district
Jimmy Gomez U.S. House of Representatives from California's 34th district — Twitter Website
0Comments

Jimmy Gomez, a U.S. Congressman representing California’s 34th district since 2017, recently addressed several key issues affecting his constituents through a series of tweets. His posts focused on affordability, federal funding cuts, and healthcare expansion efforts.

On March 18, 2025, Gomez highlighted the issue of affordability in his district, emphasizing its impact on Latino, AANHPI, and communities of color. He stated: “Affordability is the #1 issue for Latino, AANHPI, and communities of color in my district—just like everyone else struggling with rent, child care, and putting food on the table. I’m fighting to lower these costs and make America more affordable so families can thrive.”

Later that day, Gomez expressed concerns over potential budget cuts proposed by Republicans. He warned that these cuts could significantly affect California’s federal funding for Medi-Cal (Medicaid) and CalFresh (SNAP), stating: “The Republican budget proposal could strip California of tens of billions in federal funding for Medi-Cal (Medicaid) and CalFresh (SNAP). Cuts of this size would leave millions of families without access to affordable health care or food assistance.”

In another tweet on March 18, Gomez criticized former President Trump’s stance on healthcare while advocating for expanded coverage under Medicare. He announced his support for legislation co-sponsored with fellow lawmakers to broaden Medicare services: “While Trump attacks health care for seniors & people with disabilities, I’m fighting to expand it. I’m cosponsoring legislation with @RepLloydDoggett and @SenSanders to ensure Medicare covers dental, hearing & vision—because everyone should have access to the care they need.”



Related

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA

Dental Implant Specialties in Los Angeles inspected by FDA on April 5, 2024

Dental Implant Specialties in Los Angeles underwent an FDA inspection on April 5, 2024, related to human cellular, tissue, and gene therapies, according to information available on the FDA’s website.

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA

FDA conducts inspection of Good Samaritan Hospital Blood Bank in Los Angeles on Sept. 26, 2024

The FDA conducted an inspection of Good Samaritan Hospital Blood Bank in Los Angeles on September 26, 2024, focusing on blood and blood products, according to information available on the FDA’s website.

Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR)

FDA conducts inspection at Bolive, Inc. in Los Angeles on March 14, 2024

On March 14, 2024, the Food and Drug Administration conducted an inspection of Bolive, Inc. in Los Angeles focusing on foodborne biological hazards, according to information released on the FDA’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from LAX Leader.